High institutional ownership can be a signal of strong market trust in this company. 15.30% of the stock of shockwave medical is held by insiders.
Quote stock analysis news price vs fair value sustainability trailing returns financials valuation operating performance.
Shockwave medical stock analysis. Shockwave medical, inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. According to my valuation model, shockwave medical seems to be fairly priced at around 11% below my intrinsic value, which means if you buy shockwave medical today, you’d be paying a fair price. (swav) stock analyst estimates, including earnings and revenue, eps, upgrades and downgrades.
Your current $100 investment may be up to $389.33 in 2026. Do the numbers hold clues to what lies ahead for the stock? Real time shockwave medical (swav) stock price quote, stock graph, news & analysis.
Shockwave medical inc (swav) gets an overall rank of 57, which is an above average rank under investorsobserver's stock ranking system. A high percentage of insider ownership can be a sign of company health. 72% of retail cfd accounts lose money.
Dec 3, 2021 4:00 pm. Find the latest shockwave medical, inc. Is based on the most popular technical indicators — moving averages, oscillators and.
91.37% of the stock of shockwave medical is held by institutions. Try our software for free today. (swav) stock quote, history, news and other vital information to help you with your stock trading and investing.
Ad unparalleled coverage & analytic comparison. The summary for shockwave medical, inc. The company is engaged in the development of intravascular lithotripsy (ivl) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease.
Shockwave medical inc registered shs. Common stock (swav) nasdaq listed. This compares to loss of $0.38 per share a year ago.
Rating as of oct 18, 2021. Summary of all time highs, changes and price drops for shockwave medical; Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Is a medical device company. Nov 23, 2021 4:00 pm. Ad unparalleled coverage & analytic comparison.
Swav · delayed price · usd. Try our software for free today. Data is currently not available.
+0.36 (+0.17%) data as of oct 22, 2021. Nov 19, 2021 4:00 pm. Shockwave medical (swav) delivered earnings and revenue surprises of 97.56% and 28.12%, respectively, for the quarter ended june 2021.
Shockwave medical (swav) came out with quarterly earnings of $0.05 per share, beating the zacks consensus estimate of a loss of $0.07 per share. Shockwave medical (swav) reports q2 loss, tops revenue estimates.
